The PRR5-ARHGAP8 readthrough protein is a unique biological entity resulting from the transcriptional readthrough between two adjacent genes, PRR5 (Proline Rich 5) and ARHGAP8 (Rho GTPase Activating Protein 8), located on human chromosome 19. Transcriptional readthrough occurs when the transcription machinery fails to terminate properly after the first gene (PRR5) and continues into the second gene (ARHGAP8), resulting in an mRNA that encompasses both gene sequences. This mRNA can then be translated into a fusion protein that contains elements of both PRR5 and ARHGAP8 proteins.PRR5 is known to be involved in the regulation of the mTOR (mechanistic target of rapamycin) signaling pathway, which is crucial for cell growth, proliferation, and survival. ARHGAP8, on the other hand, encodes a GTPase-activating protein that regulates Rho family GTPases, which are involved in various cellular processes including actin cytoskeleton organization, cell migration, and cell cycle progression.
The PRR5-ARHGAP8 readthrough protein may thus possess combined functional domains and potentially novel properties that are distinct from those of the individual PRR5 and ARHGAP8 proteins. Its structure could allow it to interface with both mTOR signaling and Rho GTPase-mediated pathways, possibly acting as a molecular bridge that coordinates activities between these two important cellular processes.Since readthrough proteins are relatively rare and often discovered incidentally through genomic and transcriptomic studies, the functional implications of the PRR5-ARHGAP8 readthrough protein are not well-documented.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
A Rho-associated protein kinase (ROCK) inhibitor, Y-27632 might indirectly influence PRR5-ARHGAP8 by modulating downstream effects of Rho GTPase signaling. | ||||||
XL413 | 1169562-71-3 | sc-474909 | 5 mg | $275.00 | ||
ML141 is a Cdc42 GTPase inhibitor, potentially impacting signaling pathways related to ARHGAP8 function. | ||||||
Lovastatin | 75330-75-5 | sc-200850 sc-200850A sc-200850B | 5 mg 25 mg 100 mg | $29.00 $90.00 $339.00 | 12 | |
Statins inhibit HMG-CoA reductase and can influence Rho GTPase signaling indirectly, potentially impacting the function of ARHGAP8. | ||||||
Fasudil, Monohydrochloride Salt | 105628-07-7 | sc-203418 sc-203418A sc-203418B sc-203418C sc-203418D sc-203418E sc-203418F | 10 mg 50 mg 250 mg 1 g 2 g 5 g 10 g | $18.00 $33.00 $87.00 $168.00 $253.00 $496.00 $910.00 | 5 | |
Another ROCK inhibitor, Fasudil, could modulate Rho GTPase signaling pathways, indirectly affecting PRR5-ARHGAP8 functions. | ||||||
CK 666 | 442633-00-3 | sc-361151 sc-361151A | 10 mg 50 mg | $321.00 $1040.00 | 5 | |
CK-666 is an inhibitor of the Arp2/3 complex, involved in actin polymerization, and could impact pathways related to ARHGAP8. | ||||||
Latrunculin A, Latrunculia magnifica | 76343-93-6 | sc-202691 sc-202691B | 100 µg 500 µg | $265.00 $815.00 | 36 | |
This compound disrupts actin polymerization, potentially influencing cellular processes associated with ARHGAP8. | ||||||